Research library
Skin + Copper/peptide

GHK-Cu

Canonical identity: GHK-Cu

Also indexed as: Copper tripeptide-1 · Copper peptide

A copper-binding tripeptide studied in skin, extracellular-matrix, and wound-response models.

Evidence level

Preclinical evidence

Verified against the linked source set on 2026-08-20.

What it is

GHK-Cu is a copper-binding tripeptide studied in topical, cellular, and tissue-response research. Finished topical products and research-grade material are separate product classes.

Mechanism and research questions

  • Research examines copper-dependent signaling and extracellular-matrix-related pathways.
  • Results depend strongly on formulation, concentration, route, and model system.

Human evidence

Human topical studies exist in selected cosmetic or dermatologic contexts, but they do not validate every formulation or research vial.

Preclinical / mechanistic evidence

Cell and tissue models examine collagen-related, wound-response, and matrix signaling endpoints.

Evidence summary

There is a broad topical and mechanistic literature, but claims must be kept cosmetic or research-specific rather than therapeutic.

Limits and interpretation

  • Do not transfer evidence between injectable research material and finished topical formulation.
  • Copper state, formulation, purity, and skin penetration matter.
  • No medical claims or application protocol is provided for the research SKU.

Regulatory and identity note

Research peptide; finished topical products require separate cosmetic and safety documentation.

Research summaries reflect primary literature, patent landscapes, and regulatory status reports at the time of review. They do not constitute therapeutic advice, endorsement, or claims regarding unauthorized preparations.